OSTEONIC Co., Ltd.

KOSDAQ:A226400 Stock Report

Market Cap: ₩92.3b

OSTEONIC Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for OSTEONIC.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth44.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated09 Jan 2026

Recent future growth updates

No updates

Recent updates

Analysis Article • May 25

Investors Shouldn't Be Too Comfortable With OSTEONIC's (KOSDAQ:226400) Earnings

OSTEONIC Co., Ltd.'s ( KOSDAQ:226400 ) robust earnings report didn't manage to move the market for its stock. Our...
Analysis Article • Jan 02

Investors Still Waiting For A Pull Back In OSTEONIC Co., Ltd. (KOSDAQ:226400)

OSTEONIC Co., Ltd.'s ( KOSDAQ:226400 ) price-to-earnings (or "P/E") ratio of 19.6x might make it look like a sell right...
Analysis Article • May 19

Returns At OSTEONIC (KOSDAQ:226400) Are On The Way Up

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Analysis Article • Dec 27

OSTEONIC Co., Ltd.'s (KOSDAQ:226400) 28% Share Price Surge Not Quite Adding Up

OSTEONIC Co., Ltd. ( KOSDAQ:226400 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Dec 26

Returns On Capital Are Showing Encouraging Signs At OSTEONIC (KOSDAQ:226400)

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Analysis Article • Dec 07

Do OSTEONIC's (KOSDAQ:226400) Earnings Warrant Your Attention?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Nov 19

There May Be Underlying Issues With The Quality Of OSTEONIC's (KOSDAQ:226400) Earnings

Despite announcing strong earnings, OSTEONIC Co., Ltd.'s ( KOSDAQ:226400 ) stock was sluggish. We think that the market...
Analysis Article • Nov 15

Does OSTEONIC (KOSDAQ:226400) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Aug 09

OSTEONIC (KOSDAQ:226400) Is Experiencing Growth In Returns On Capital

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...
Analysis Article • Mar 31

There May Be Underlying Issues With The Quality Of OSTEONIC's (KOSDAQ:226400) Earnings

Despite posting some strong earnings, the market for OSTEONIC Co., Ltd.'s ( KOSDAQ:226400 ) stock hasn't moved much...
Analysis Article • Feb 27

OSTEONIC (KOSDAQ:226400) Seems To Use Debt Rather Sparingly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Mar 25

Is Osteonic (KOSDAQ:226400) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as OSTEONIC has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A226400 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202660,10011,8005,0005,0001
3/31/202648,7659,393-3,4419,554N/A
12/31/202545,3937,4991799,016N/A
9/30/202542,1146,501-2,7334,750N/A
6/30/202538,4005,757-7875,711N/A
3/31/202536,0696,371-1,0795,195N/A
12/31/202434,2355,650-2,1644,719N/A
9/30/202432,5436,181-4,4844,960N/A
6/30/202431,1255,882-5,4763,956N/A
3/31/202429,2474,445-7,5473,932N/A
12/31/202327,7993,658-2,8334,140N/A
9/30/202325,9734701,0375,597N/A
6/30/202324,342-4529455,670N/A
3/31/202322,131-1712,2134,821N/A
12/31/202219,8398361,6793,985N/A
9/30/202218,1162,3453402,748N/A
6/30/202217,2692,264-1492,912N/A
3/31/202216,338-70-6563,486N/A
12/31/202115,598-2,852-8762,946N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A226400's forecast earnings growth is above the savings rate (3.1%).

Earnings vs Market: Insufficient data to determine if A226400's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A226400's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A226400's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A226400's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A226400's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/23 03:08
End of Day Share Price 2026/07/23 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OSTEONIC Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yeon Sung JungNH Investment & Securities Co., Ltd.
Sun-Jae HeoSK Securities Co., Ltd.